Should serum biomarker monitoring replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy?

This website uses cookies.

We use cookies and similar tools that are necessary to enhance your experiences and to provide our services as detailed in our Cookie Policy. We also use these cookies to understand how customers use our services so we can make improvements.